Ebola-infected Spanish nurse improving after dose of experimental drug ZMapp: health source

Spain’s Ebola patient is feeling better just hours after she received an experimental treatment, health sources said.

Teresa Romero is still in serious condition at Carlos III Hospital in Madrid, but she is improving, a health source told AFP Saturday. Late Friday she was given a dose of ZMapp, a U.S.-made drug that’s not yet been clinically tested.

“(She) is quite a bit better than yesterday. Her condition improved in the night. She is conscious and talks from time to time when she is in a good mood,” the source said.

Romero was diagnosed with Ebola on Oct. 6, becoming the first pirson to contract the disease outside of West Africa.

She developed the virus in Spain while caring for an Ebola-infected priest.

Miguel Pajares, 75, was airlifted from Liberia, where he worked as a Catholic missionary, to Madrid in August, but died a week after entering the Spanish hospital where Romero worked. Before he died, he, too, was given ZMapp.

The experimental drug was also given to two American health workers who developed Ebola in Liberia. Kent Brantly and Nancy Writebol both recovered after they were airlifted from West Africa to Atlanta earlier this year.

The 2014 Ebola outbreak is concentrated in three West African countries: Guinea, Liberia and Sierra Leone. Smaller outbreaks have been reported in Senegal and Nigeria.

Since the March onset of the outbreak, 8399 people have developed the disease. At least 4033 of those cases were fatal, the World Health organization reported.

The following two tabs change content below.
Dan Mullin is an active writer and editor for the Pluto Daily who covered the 2014 Ebola Outbreak. Mullin attended the Wake Forest School of Medicine before leaving to pursue his lifelong science goal of allowing humans to live forever via a computer/brain transfer.